P3 Health Partners
PIII
46 hedge funds and large institutions have $12.4M invested in P3 Health Partners in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 16 reducing their positions, and 20 closing their positions.
3.89% less ownership
Funds ownership: 23.72% → 19.83% (-3.9%)
23% less funds holding
Funds holding: 60 → 46 (-14)
28% less capital invested
Capital invested by funds: $17.2M → $12.4M (-$4.83M)
65% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 20
69% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$993K |
| 2 |
Corient Private Wealth
Miami,
Florida
|
+$905K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$289K |
| 4 |
AWC
Abundance Wealth Counselors
State College,
Pennsylvania
|
+$210K |
| 5 |
Renaissance Technologies
New York
|
+$195K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.85M |
| 2 |
AC
Armistice Capital
New York
|
-$655K |
| 3 |
Goldman Sachs
New York
|
-$244K |
| 4 |
Jane Street
New York
|
-$148K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$132K |
PIII Hedge Fund Activity: Q3 2024 in Review
46 of the 6,981 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q3 2024, worth a combined $12.4M — down 28% from $17.2M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of PIII and 7 opened new positions — a net loss of 13 holders — while 16 trimmed existing stakes and 5 added.
The largest buyer was Morgan Stanley, adding an estimated $993K. The largest seller was Ameriprise, exiting entirely with an estimated $2.85M sold.
- 46 institutional investors held P3 Health Partners (PIII) as of Q3 2024, down from 60 in Q2 2024.
- Funds reported $12.4M of P3 Health Partners stock for Q3 2024, down 28% quarter-over-quarter.
- 7 funds opened new P3 Health Partners positions in Q3 2024 and 20 closed out, a net change of -13 holders.
- The largest P3 Health Partners buyer in Q3 2024 was Morgan Stanley, an estimated $993K added.
- The largest P3 Health Partners seller in Q3 2024 was Ameriprise, an estimated $2.85M sold.
Based on aggregated 13F filings for Q3 2024.